Key research themes
1. How do biopsychosocial and neurogastroenterological mechanisms contribute to bowel dysfunction pathophysiology and symptom heterogeneity?
This research theme explores the multifactorial etiologies and mechanisms underlying bowel dysfunction, particularly in conditions such as irritable bowel syndrome (IBS) and functional gastrointestinal disorders (FGIDs). It emphasizes the interplay of altered gut motility, visceral hypersensitivity, neuroimmune interactions, brain-gut axis dysregulation, psychosocial factors, and genetic/environmental influences. Understanding these complex interactions is critical for improving diagnostic frameworks and developing targeted, personalized therapies.
2. What are the neuropathological and physiological abnormalities underpinning severe bowel dysfunction including obstructed defecation and neurogenic bowel dysfunction?
This theme investigates structural and functional alterations in the enteric nervous system, colonic motility, and bowel neural control that manifest in severe bowel dysfunction syndromes such as obstructed defecation and neurogenic bowel dysfunction (NBD). Research focuses on histopathological changes, including neuronal and glial cell abnormalities, as well as the clinical utility of advanced diagnostic techniques and management strategies for pediatric and adult populations with neurogenic or obstructive etiologies.
3. What are the clinical diagnostic criteria, epidemiological characteristics, and evidence-based management strategies for irritable bowel syndrome and related functional bowel disorders?
This theme encompasses evidence-based approaches to the diagnosis and management of IBS and functional bowel disorders, with emphasis on symptom-based criteria (primarily Rome classifications), epidemiological variation across populations, and the integration of clinical guidelines tailored to geographic and resource contexts. It also involves strategies for effective communication, minimizing stigma, and the use of both conventional and novel therapeutics including pharmacologic, behavioral, and microbiome-targeting interventions.